机械细胞内PK/PD建模,以告知小干扰RNA治疗方法的开发策略
Lin Chen1, Caroline Bosmajian1, Sukyung Woo1
1Division of Pharmacokinetics-Pharmacodynamics and Systems Pharmacology, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, NY 14214, USA.
Molecular therapy. Nucleic acids
|April 17, 2025
概括
小干扰RNA (siRNA) 疗法可以使基因沉默,但细胞分裂和mRNA周转等因素会影响它们的成功,特别是在肝脏外. 我们的模型揭示了这些因素如何影响基因淘汰的持续时间和程度,从而改善治疗设计.
科学领域:
- 药理学和分子生物学
- 基因沉默技术是一种技术.
- 治疗开发的治疗方法
背景情况:
- 小干扰RNA (siRNA) 疗法提供有针对性的基因沉默,在肝脏应用中已证明有效性.
- 了解siRNA特性和生物因素对基因淘汰的定量影响,特别是对于肝外点,仍然是一个挑战.
- 影响siRNA疗效的关键因素包括siRNA稳定性,向亲和力,细胞增殖率,mRNA周转率和mRNA丰度.
研究的目的:
- 确定控制由siRNA调解的基因淘汰程度和持续时间的关键决定因素.
- 开发一种机械的细胞内药理动力学/药理动力学 (PK/PD) 模型,用于使用RNAiMAX.RNA的siRNA输送.
- 研究细胞和分子因素对快速和缓慢分裂细胞中的siRNA疗效的影响.
主要方法:
- 开发了一种机械的细胞内PK/PD模型,用于siRNA配置,RISC加载和mRNA淘汰.
- 利用了针对不同基因的MCF7和BT474细胞系中siRNA递送的数据.
- 分析了细胞增殖,mRNA循环率,siRNA稳定性和RISC占用对基因沉默结果的影响.
主要成果:
- 细胞增殖显著影响基因沉默的持续时间,而mRNA循环率决定了淘汰的程度.
- 在快速分裂的细胞中,mRNA的半衰期是击倒特征的主要驱动因素;siRNA的化学稳定延长了缓慢分裂的细胞中的沉默.
- 对具有非常低或非常高mRNA丰度的目标来说,最佳的基因沉默具有挑战性.
- 充分的RISC占用是必要的,但增加RISC暴露产生的回报减少;增强siRNA-mRNA目标参与是更有效的敲击程度.
结论:
- 机械PK/PD建模为优化siRNA治疗外肝标提供了关键的见解.
- 细胞增殖,mRNA半衰期和RISC介导的分裂率量化地定义了最大的mRNA淘汰.
- 这些发现指导了更好的siRNA设计和目标选择策略,以改善治疗开发和疗效.
相关概念视频
02:30siRNA - Small Interfering RNAs
16.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.3K
02:15Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
15
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
15
02:30Small interfering RNAs (siRNA)
3.4K
3.4K
01:23RNA Interference
25.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.8K
01:26Pharmacokinetic Models: Comparison and Selection Criterion
21
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
21